Literature DB >> 7076679

Reversible modification of human plasma low density lipoproteins toward triglyceride-rich precursors. A mechanism for losing excess cholesterol esters.

R J Deckelbaum, S Eisenberg, Y Oschry, E Butbul, I Sharon, T Olivecrona.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7076679

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  25 in total

1.  Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.

Authors:  Richard E Morton; Diane J Greene
Journal:  J Lipid Res       Date:  2011-09-21       Impact factor: 5.922

Review 2.  Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.

Authors:  A R Tall
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

Review 3.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

4.  Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design.

Authors:  Richard E Morton; Lahoucine Izem
Journal:  J Lipid Res       Date:  2015-01-23       Impact factor: 5.922

5.  Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.

Authors:  H N Ginsberg; N A Le; J C Gibson
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  The changes in plasma lipoproteins in rat with diabetes induced by streptozotocin.

Authors:  G Cheng; Z C Feng; Y T Huang
Journal:  J Tongji Med Univ       Date:  1988

7.  Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase.

Authors:  J R Patsch; S Prasad; A M Gotto; G Bengtsson-Olivecrona
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

8.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

Authors:  S Eisenberg; D Gavish; Y Oschry; M Fainaru; R J Deckelbaum
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro.

Authors:  Laura K Potter; Dennis L Sprecher; Max C Walker; Frank L Tobin
Journal:  J Lipid Res       Date:  2009-03-11       Impact factor: 5.922

10.  Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.

Authors:  F T Yen; R J Deckelbaum; C J Mann; Y L Marcel; R W Milne; A R Tall
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.